Multiple Sclerosis. Demyelinating diseases of the central nervous system
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Satisfaction to participate in the study Patient with multiple sclerosis of any type and with moderate and high depression Not receive repeated transcranial magnetic stimulation and electroconvulsive therapy in the past two months
Exclusion criteria
Exclusion criteria: Having a shunt and any other metal object near the head Interferon consumption Pregnant or lactating women Patients at risk of suicide Patients with other psychiatric disorders such as bipolar disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression rate. Timepoint: before and after 10 sessions of intervention. Method of measurement: Montgomery-Asberg Depression Rating Scale (MADRS).;Fatigue severity test. Timepoint: before and after 10 sessions of intervention. Method of measurement: Fatigue Severity Scale.;Expanded Disability Status Scale. Timepoint: before and after 10 sessions of intervention. Method of measurement: Expanded Disability Status Scale.;Cognitive Assessment. Timepoint: before and after 10 sessions of intervention. Method of measurement: Montreal Cognitive Assessment. | — |
Countries
Iran (Islamic Republic of)
Contacts
Hamedan University of Medical Sciences